Filed in archive
Drugs, Vaccines and Therapeutics
by ruth on January 28, 2006

"Until today, patients with diabetes who need insulin to manage their disease had only one way to treat their condition," said Dr. Steven Galson, director of the FDA's Center for Drug Evaluation and Research. "It is our hope that the availability of inhaled insulin will offer patients more options to better control their blood sugars."
There is still one caveat:
Use of rapid-acting inhaled insulin will not replace the need to occasionally inject the hormone, according to the FDA. And diabetics would have to continue pricking their fingers to test blood sugar levels.
Pharma's Cutting Edge Blog provides a comprehensive review of the newly-approved Exubera label provided by the FDA.
Research to produce even better versions are still ongoing, with at least four other companies developing their versions of own inhalable insulin: Eli Lilly and Co., Kos Pharmaceuticals Inc., MannKind Corp. and Novo Nordisk A/S.
Photo: From Pfizer, viaTripleHelix
Permalink: Inhalable Insulin Exubera Approved By FDA
Tags:
diabetes
insulin
biotech
inhalable
approved
inhalable+insulin
insulin+exubera
exubera+approved
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/14595
Mr Wong
Vote for Inhalable Insulin Exubera Approved By FDA:
|
Rating: 7.50 out of 4 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |







